Clinical Trials Logo

Clinical Trial Summary

The aim of this study to increase understanding of physiological and functional perturbations following a continuum of exercise stressors.


Clinical Trial Description

This study utilised a between groups design, with a within-groups control. This allowed the within-subject profiling of recovery during both a control and exercise week. This design also allowed each group to perform an ecologically valid exercise session as well as having markers of recovery tailored to the areas of interest specific to each cohort. By having each group perform a non-exercise control week, this gives valuable information on the reliability and smallest worthwhile change for a range of both novel and commonly used recovery markers. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03083509
Study type Interventional
Source GlaxoSmithKline
Contact
Status Completed
Phase N/A
Start date January 1, 2016
Completion date July 29, 2016

See also
  Status Clinical Trial Phase
Completed NCT02112695 - Opioid System Cerebral Activity in Endurance Sportswomen - Addiction or Denutrition ? [11C]Diprenorphine PET Study N/A
Not yet recruiting NCT05489666 - Effects of Vitamin D on Skeletal Muscle Strength in Resistance Trained Adult Females N/A
Completed NCT02519751 - New Method Using Deuterium Labelled Creatine to Measure Total Body Skeletal Muscle Mass N/A
Completed NCT04642144 - Effect of Infusion of Yerba Mate on Oxidative Stress, Physiology, and Performance of Trained Cyclists N/A
Completed NCT02458599 - Efficacy Study of Protein Supplementation in Attenuating the Decline in Performance After Strenuous Concurrent Exercise N/A